Glycosphingolipid composition of human immunodeficiency virus type 1 (HIV-1) particles is a crucial determinant for dendritic cell-mediated HIV-1 trans-infection.
about
CD169-dependent cell-associated HIV-1 transmission: a driver of virus disseminationSialyllactose in viral membrane gangliosides is a novel molecular recognition pattern for mature dendritic cell capture of HIV-1CD169-mediated trafficking of HIV to plasma membrane invaginations in dendritic cells attenuates efficacy of anti-gp120 broadly neutralizing antibodiesRetroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection.Restrictions to cross-species transmission of lentiviral infection gleaned from studies of FIVHIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infectionUterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cellsGlycosphingolipid-functionalized nanoparticles recapitulate CD169-dependent HIV-1 uptake and trafficking in dendritic cellsVirus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus.The Role of Lipids in Retrovirus Replication.Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis.Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.ELIGLUSTAT TARTRATE: Glucosylceramide Synthase Inhibitor Treatment of Type 1 Gaucher Disease.Characterization of HIV-1 envelopes in acutely and chronically infected injection drug usersDendritic Cells and HIV-1 Trans-Infection.Dendritic cells in progression and pathology of HIV infection.Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169.HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1Quantifying lipid contents in enveloped virus particles with plasmonic nanoparticlesTransmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection.HIV-1 incorporation of host-cell-derived glycosphingolipid GM3 allows for capture by mature dendritic cells.Dynamic Association between HIV-1 Gag and Membrane Domains.Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1.Cellular and viral mechanisms of HIV-1 transmission mediated by dendritic cellsRole of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection.Cell-Free versus Cell-to-Cell Infection by Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Type 1: Exploring the Link among Viral Source, Viral Trafficking, and Viral Replication.HIV interactions with monocytes and dendritic cells: viral latency and reservoirs.HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting CellsThe multiple facets of HIV attachment to dendritic cell lectins.A mechanistic overview of dendritic cell-mediated HIV-1 trans infection: the story so far.Spontaneous Mutation at Amino Acid 544 of the Ebola Virus Glycoprotein Potentiates Virus Entry and Selection in Tissue Culture.Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated.Probing HIV-1 membrane liquid order by Laurdan staining reveals producer cell-dependent differences.Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon.Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.Plasmonic Enhancement of Selective Photonic Virus InactivationSensitivity changes over the course of infection increases the likelihood of resistance against fusion but not CCR5 receptor blockers.Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses.The Biology of Monocytes and Dendritic Cells: Contribution to HIV Pathogenesis.
P2860
Q27008186-9AD8B558-D101-4E4F-93A2-EDFC2EA0E8DBQ27319569-D29C99F3-7223-41AE-A48A-F925C2307481Q27320842-7AC9E64E-3544-4F2D-9625-33524A891750Q27331323-737C38CA-E5D0-474F-B622-63EBE7F4645DQ33515462-B4F1D569-ACA3-40A9-BD31-732B4E7F25CDQ33548656-2BC6C1A6-F06D-4B77-8A99-0460FA528523Q33628817-7ADFD04F-332F-4A59-B4B9-6148E0D45C2BQ33778508-3DF2C571-6869-4B73-8F0C-3F2C7C67EAEAQ33943688-C2EAFFD8-AE58-40E4-8383-E4562F05FD2AQ34059163-F9B957BD-4F6E-4902-BE2C-E1AAC6FF6EF3Q34080779-A1BBF650-026F-4BBF-8C86-49FECF677526Q34170655-5B213813-BF63-438A-949D-D52296C48B21Q34253227-40FF1528-E386-4500-8519-1C820772B831Q34273177-CA1950B3-A54C-4875-8846-92B0F14EEA3BQ34620235-48BA5760-D630-4C2D-847F-BD38FDB376A7Q34632997-9E1274C7-3443-4C7D-BBAE-854D9F3AADC6Q34657557-B7C9E124-4526-4DA3-A741-1AA3E859FCDEQ34671896-9F2EB35A-1293-4D95-B20F-98FDC469C868Q35208189-681FDA03-EC8E-4B86-91DD-188457BA0DF9Q35659750-DB0B8A19-64AF-4338-B3B6-E0478673F934Q35842299-C548684A-50A7-4BB5-91A6-D358C2CF5685Q35982750-7CFAC9A2-61DC-45C8-AC62-A30F56B244EEQ36102200-53DDB026-D133-4ECC-B20F-F7BA9DBEF07BQ36262599-0E919C1A-ADF4-4A5F-8558-7C0CBBB62820Q36448906-BDB5F5A4-881E-4C7A-9E85-BD0A663F817CQ36940332-E97A72F9-96A6-4FED-A66C-2119E9E96095Q37182721-8B266B44-59B9-43AE-BE08-13EFD873B40AQ37229398-968E4291-9BDD-4773-9E58-275FAFC4CF3DQ37287774-0C693F41-DCDB-4554-B365-D4DD5C2999DBQ37790420-EA688362-EEDC-4793-8BBD-66F57C034B86Q38554932-DC0D37EB-6F33-4291-8D5C-F26E529E2483Q38702384-D39B9D6A-72E4-4CEE-AC0E-652E610A9D06Q38752077-0ADB80C8-7C1A-4C19-A8F4-D8721052BD02Q39833520-862096B2-A601-4A68-B818-36C6DC8190B2Q40088680-24633A01-666A-4BC2-9879-FE0FDE071A82Q40235566-E396CFDE-9D63-421A-AD78-31B70CC2FE3FQ41696803-588503C4-7F33-4359-AC84-F2F79CC6D359Q42348438-6A49677F-B3F7-475C-9F6F-98CB47CCE0A2Q46202850-7813B1B5-17A9-4F47-A916-92C2DC3C5AC2Q50131761-DE25B0F6-7BB8-4538-A92E-CA429A4C6BE4
P2860
Glycosphingolipid composition of human immunodeficiency virus type 1 (HIV-1) particles is a crucial determinant for dendritic cell-mediated HIV-1 trans-infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glycosphingolipid composition ...... ediated HIV-1 trans-infection.
@en
Glycosphingolipid composition of human immunodeficiency virus type 1
@nl
type
label
Glycosphingolipid composition ...... ediated HIV-1 trans-infection.
@en
Glycosphingolipid composition of human immunodeficiency virus type 1
@nl
prefLabel
Glycosphingolipid composition ...... ediated HIV-1 trans-infection.
@en
Glycosphingolipid composition of human immunodeficiency virus type 1
@nl
P2860
P356
P1433
P1476
Glycosphingolipid composition ...... ediated HIV-1 trans-infection.
@en
P2093
Jacob Archer
Steven C Hatch
P2860
P304
P356
10.1128/JVI.02249-08
P407
P577
2009-02-04T00:00:00Z